Philips says it has completed actionable registrations across sleep therapy and ventilator devices and is closing the U.S. Patient Portal related to its recall as of Jan. 1, 2026.
ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role ...
Recalled breathing assistance devices from Philips Respironics have been linked to 561 deaths, federal regulators said Wednesday. The death toll is an update to the U.S. Food and Drug Administration's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results